232 related articles for article (PubMed ID: 2532457)
1. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists.
Johnston CI; Hodsman PG; Kohzuki M; Casley DJ; Fabris B; Phillips PA
Am J Med; 1989 Dec; 87(6B):24S-28S. PubMed ID: 2532457
[TBL] [Abstract][Full Text] [Related]
2. Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide.
O'Tierney PF; Komolova M; Tse MY; Adams MA; Pang SC
J Hypertens; 2008 Feb; 26(2):303-11. PubMed ID: 18192845
[TBL] [Abstract][Full Text] [Related]
3. [Does atrial antipressor natriuretic peptide play a pathophysiological role?].
Bühler FR
Schweiz Med Wochenschr; 1987 Dec; 117(49):1930-7. PubMed ID: 2962281
[TBL] [Abstract][Full Text] [Related]
4. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Kjaer A; Hesse B
Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
[TBL] [Abstract][Full Text] [Related]
5. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis.
Atlas SA; Laragh JH
Annu Rev Med; 1986; 37():397-414. PubMed ID: 2939792
[TBL] [Abstract][Full Text] [Related]
7. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide: water and electrolyte homeostasis.
Kenyon CJ; Jardine AG
Baillieres Clin Endocrinol Metab; 1989 Aug; 3(2):431-50. PubMed ID: 2560911
[TBL] [Abstract][Full Text] [Related]
9. Oleanolic acid modulates the renin-angiotensin system and cardiac natriuretic hormone concomitantly with volume and pressure balance in rats.
Ahn YM; Choi YH; Yoon JJ; Lee YJ; Cho KW; Kang DG; Lee HS
Eur J Pharmacol; 2017 Aug; 809():231-241. PubMed ID: 28514645
[TBL] [Abstract][Full Text] [Related]
10. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide and its potential role in pharmacotherapy.
Deutsch A; Frishman WH; Sukenik D; Somer BG; Youssri A
J Clin Pharmacol; 1994 Dec; 34(12):1133-47. PubMed ID: 7738207
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Thibault G; Haass M; Höhnel K; Bohlender J; Luft FC; Dietz R
Cardiovasc Res; 1999 Jun; 42(3):733-42. PubMed ID: 10533614
[TBL] [Abstract][Full Text] [Related]
13. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
Selçuk Y; San A; Bakan E; Yiğitoğlu R
Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide inhibits the effect of endogenous angiotensin II on plasma aldosterone in conscious sodium-depleted rats.
Chartier L; Schiffrin EL
Clin Sci (Lond); 1987 Jan; 72(1):31-5. PubMed ID: 2948755
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man.
Anderson JV; Struthers AD; Payne NN; Slater JD; Bloom SR
Clin Sci (Lond); 1986 May; 70(5):507-12. PubMed ID: 2938872
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
17. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
[TBL] [Abstract][Full Text] [Related]
18. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the renin-angiotensin system by atrial natriuretic peptide.
Johnston CI; Phillips PA; Arnolda L; Mooser V
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S43-6. PubMed ID: 1708022
[TBL] [Abstract][Full Text] [Related]
20. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
Grandis DJ; Uretsky BF; Verbalis JG; Chong TK; Puschett JB
Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
